0001437749-22-018053.txt : 20220728
0001437749-22-018053.hdr.sgml : 20220728
20220728212357
ACCESSION NUMBER: 0001437749-22-018053
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220726
FILED AS OF DATE: 20220728
DATE AS OF CHANGE: 20220728
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: E&Investment, Inc.
CENTRAL INDEX KEY: 0001796144
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37809
FILM NUMBER: 221116959
BUSINESS ADDRESS:
STREET 1: 16TH FLOOR, YEOKSAM I-TOWER
STREET 2: B/D 326, TEHERAN-RO, GANGNAM-GU
CITY: SEOUL
STATE: M5
ZIP: 00000
BUSINESS PHONE: 82-2-501-3714
MAIL ADDRESS:
STREET 1: 16TH FLOOR, YEOKSAM I-TOWER
STREET 2: B/D 326, TEHERAN-RO, GANGNAM-GU
CITY: SEOUL
STATE: M5
ZIP: 00000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: E&Healthcare Investment Fund II
CENTRAL INDEX KEY: 0001799534
STATE OF INCORPORATION: M5
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37809
FILM NUMBER: 221116958
BUSINESS ADDRESS:
STREET 1: 16TH FLOOR, YEOKSAM I-TOWER, 326
STREET 2: TEHERAN-RO, GANGNAM-GU
CITY: SEOUL
STATE: M5
ZIP: 06211
BUSINESS PHONE: 82-2-501-3714
MAIL ADDRESS:
STREET 1: 16TH FLOOR, YEOKSAM I-TOWER, 326
STREET 2: TEHERAN-RO, GANGNAM-GU
CITY: SEOUL
STATE: M5
ZIP: 06211
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NeuroBo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001638287
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472389984
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 BERKELEY ST.
STREET 2: FL 19
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: (857) 702-9600
MAIL ADDRESS:
STREET 1: 200 BERKELEY ST.
STREET 2: FL 19
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: Gemphire Therapeutics Inc.
DATE OF NAME CHANGE: 20150331
4
1
rdgdoc.xml
FORM 4
X0306
4
2022-07-26
0001638287
NeuroBo Pharmaceuticals, Inc.
NRBO
0001796144
E&Investment, Inc.
C/O NEUROBO PHARMACEUTICALS, INC.
200 BERKELEY STREET, OFFICE 19TH FLOOR
BOSTON,
MA
02116
1
0001799534
E&Healthcare Investment Fund II
C/O NEUROBO PHARMACEUTICALS, INC.
200 BERKELEY STREET, OFFICE 19TH FLOOR
BOSTON,
MA
02116
1
Common Stock
2022-07-26
4
J
0
1445267
0
D
2890533
I
Held by The E&Healthcare Investment Fund II
Common Stock
140147
D
Common Stock
1121190
I
Held by The E&Healthcare Investment Fund No. 6
Common Stock
1864799
I
Held by The E&Healthcare Investment Fund No. 7
E&Healthcare Investment Fund II distributed 1,445,267 shares to its partners on a pro rata basis, for no consideration.
These shares are owned directly by The E&Healthcare Investment Fund II, a 10% owner of the Issuer, and indirectly by its sole general partner, E&Investment, Inc.
E&Investment, Inc. disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
E&Investment, Inc. received a pro rata distribution from E&Healthcare Investment Fund II.
These shares are owned directly by The E&Healthcare Investment Fund No. 6, and indirectly by its sole general partner, E&Investment, Inc.
These shares are owned directly by The E&Healthcare Investment Fund No.7, and indirectly by its sole general partner, E&Investment, Inc.
/s/ E&I Investment, Inc., By: Na Yeon Kim, CEO
2022-07-28
/s/ The E&Healthcare Investment Fund II, By: Na Yeon Kim, Representative Director
2022-07-28